Moderna

-$18.40 (-5.42%) As of 4:17 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Moderna and other ETFs, options, and stocks.

About MRNA

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics.

CEO

Stéphane Bancel

Employees

1,300

Headquarters

Cambridge, Massachusetts

Founded

2010

MRNA Key Statistics

Market Cap

129.64B

Price-Earnings Ratio

42.39

Dividend Yield

—

Average Volume

10.45M

High Today

$335.75

Low Today

$317.18

Open Price

$333.00

Volume

4.88M

52 Week High

$497.49

52 Week Low

$65.49

MRNA News

BenzingaOct 21

Corona Doom 2.0: Carter Worth Warns That Vaccine-Maker Moderna May Have Further To Fall. What To Do If You're Long.

Moderna: Look Out Below? COVID-19 vaccine maker Moderna, Inc. (NASDAQ: MRNA) was our top name in late August... Screen capture via Portfolio Armor on 8/26/202

BenzingaOct 21

Baillie Gifford Trimmed Positions In Alibaba, Tesla, Nio, Moderna In Q3, Here's What It Bought Instead - Alibaba

Investment firm Baillie Gifford lowered exposure in Tesla Inc (NASDAQ:TSLA), Alibaba Group Holding (NYSE:BABA) and Nio Inc (NYSE:NIO) in the third quarter and s

BenzingaOct 18

Why Moderna Shares Are Rebounding From Friday's Losses - Moderna

Moderna, Inc. (NASDAQ:MRNA) shares have followed a downtrend ever since completing a double top formation in late September. After bottoming in early October, t

Analyst Ratings

44%

of 16 ratings

Buy

31.3%

Hold

43.8%

Sell

25%

MRNA Earnings

-$0.69

$1.69

$4.08

$6.46

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Q2 FY21

Q3 FY21

Estimated

— per share

Actual

Available Nov 4, Pre-Market